Form D · Biotechnology
Smart Pill Corp
Buffalo, NY · CIK 0001320958
Offering snapshot reported Aug 13, 2010 · SEC filing
- Reported sold
- $9.52M Offering amount: $9.52M
- Investors reported
- 71 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jun 18, 2010 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$7,950,000 → $9,517,008
- Reported investors6 → 71
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2010 | Amendment | $9,517,008 | $1,567,008vs Jul 2, 2010 | 71 | SEC filing |
| Jul 2, 2010 | Initial | $7,950,000 | No comparison | 6 | SEC filing |
| Apr 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 20, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 3, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 19, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 27, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 2, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 23, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 11, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 15, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144405
No Sales Commissions or Finders Fees will be paid
Source: Form D, filed Aug 13, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Omar Amirana | Director |
| David L Barthel | Director, Executive |
| Austin Broadhurst, Jr | Director |
| Jeffrey Krauss | Director |
| Bela Musits | Director |
| Joseph Riley | Director |
| Brian Wagner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
847 Main St
Buffalo, NY, 14203
Buffalo, NY, 14203